---
layout: paper
title: Publicatons in 2010
image: /images/papers/papers-2010.jpg
authors:  Hallett M  
year: 2010
---


<br> <br>


Rose AA, Annis MG, Dong Z, <em>Pepin F</em>, <strong>Hallett M</strong>, Park M, Siegel PM (2010) ADAM10 releases a soluble form of the GPNMB/Osteoactivin extracellular domain with angiogenic properties. PLoS One 5(8):e12093. PMID: 20711474. 

Ursini-Siegel J, <em>Cory S</em>, Zuo D, Hardy W, Rexhepaj E, LamS, Schade B, Jirstrom K, Bjur E, Piccirillo C, DeNardo D, Coussens L,Brennan D, Gallagher W, Park M, Pawson T, <strong>Hallett M</strong>, Muller W (2010) Receptor Tyrosine Kinase Signaling in Breast Cancer Cells Inhibits the Adaptive Immune Response to Favor a Pro-Tumorigenic State. Cancer Research 70(20):7776-87. PMID: 20924104.

<em>Perkins T,</em> <strong>Hallett M</strong>. (2010) A trade-off between sample complexity and computational complexity in learning Boolean networks from time series data. Transactions on Computational Biology and Bioinformatics 7(1):118-25. PMID: 20150674


Muggerud AA, <strong>Hallett M</strong>, Johnsen H, Kleivi K, Zhou W, Tahmasebpoor S, Amini RM, Botling J, Børresen-Dale AL, Sørlie T, Wärnberg F (2010) Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer. Molecular Oncology 4(4):357-68. PMID: 20663721.


<em>Lee AY</em>, Perreault R, Harel S, Boulier E, <em>Suderman M,</em> <strong>Hallett M</strong>, Jenna S (2010) Searching for Signaling Balance through the Identification of Genetic Interactors of the Rab Guanine-Nucleotide Dissociation Inhibitor <em>gdi-1</em> PLoS ONE 5(5):e10624. PMID: 20498707. 

Epp E, Vanier G, Harcus D, <em>Lee AY</em>, Jansen G, <strong>Hallett M</strong>, Sheppard D, Thomas D, Munro CA, Mullick A, Whiteway M (2010) Reverse Genetics in <em>Candida albicans</em> Predicts ARF Cycling is Essential for Drug Resistance and Virulence. PLoS Pathogens 6(2):e1000753. PMID: 20140196. 

Rose AA, Grosset A-A, Dong Z, Russo C, MacDonald P, Bertos N, St-Pierre Y, Simantov R, <strong>Hallett M</strong>, Park M, Gaboury L, Siegel P (2010) GPNMB is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer. Cancer Research 16(7):2147-56. PMID: 20215530. 
